
Edwards Lifesciences (NYSE:EW) insiders aren’t buying, and they haven’t been for several months, according to a report.
Although insiders have been selling shares, 3 of them in the last week, none have purchased any since at least April, SeekingAlpha reported.
During that time shares have gained nearly 40% from an opening price of $72.78 on April 2 to yesterday’s close at $101.08.
Insider trades in the last week include by chief financial officer Thomas Abate, who sold 20,000 share on August 24; Japan & Asia Pacific corporate vice president Huimin Wang, who sold 15,000 shares on August 28; and director John Cardis, who sold 7,000 shares on August 27, according to SeekingAlpha.
That respectively amounts to at least $2 million, $694,000 and $1.5 million in value for each sales, based on the lowest Wall Street trading value for those days.
BSD Medical launches dirt sales into major U.S. cities
BSD Medical Corp. (NSDQ:BSDM) expanded its MicroThermX microwave ablation system sales into major U.S. cities through a direct sales program. New coverage includes cities in Florida, New York, New Jersey, Philadelphia, Chicago, Detroit, Phoenix, Las Vegas, southern California, Dallas and Houston. Read more
Varian Medical (NYSE:VAR), maker of the TrueBeam radiosurgery systems, launched a new subsidiary in South Korea, which will help roll out the company’s flagship technology in that country. Read more
Wright Medical (NSDQ:WMGI) last week priced a $260 million offering of convertible senior notes due 2017, which will be sold to qualified institutional investors. Wright also authorized an additional $40 million in principal notes to cover over-allotments. The company expects the offering to close by the end of August. Read more
Medical device integration services provider iSirona ranked 82nd in Inc. 500’s list of the fastest-growing private companies in the U.S. Read more
Montgomery, Pa.-based PhotoMedex (NSDQ:PHMD) announced that its board of directors authorized a $25 million share repurchase program, to take place over the next 12 months and to be paid for with cash on hand.
Read more
Teleflex (NYSE:TFX) signed 2 new deals with group purchasing organizations, agreeing to provide CV catheters to HealthTrust Purchasing and respiratory products to Premier healthcare alliance. Read more
- C.R. Bard (NYSE:BCR): Zacks Equity Research reiterates "neutral" rating
- Endo Pharmaceuticals Holdings (NSDQ:ENDP): J.P. Morgan reiterates "overweight" rating, $48.00 price target
- Globus Medical (NYSE:GMED): Bank of America initiates coverage with $17 price target and “buy” rating
- Intuitive Surgical (NSDQ:ISRG): Goldman Sachs lowers price target from $594 to $556, reiterates “neutral” rating
- Medtronic (NYSE:MDT): Cowen reaffirms “outperform” rating
- St. Jude Medical (NYSE:STJ): Piper Jaffray maintains “overweight” rating, $40 price target
- Varian Medical (NYSE:VAR): Goldman Sachs raises price target from $50 to $52, reiterates “sell” rating
- Zeltiq (NSDQ:ZLTQ): Goldman Sachs lowers price target from $6 to $5.80, reiterates “neutral” rating